相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells
Bok Sil Hong et al.
BMC GENOMICS (2009)
Proliferation of Immature Tumor Vessels Is a Novel Marker of Clinical Progression in Prostate Cancer
Karsten Gravdal et al.
CANCER RESEARCH (2009)
Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer
Bianca Mostert et al.
CANCER TREATMENT REVIEWS (2009)
Tumor Self-Seeding by Circulating Cancer Cells
Mi-Young Kim et al.
CELL (2009)
Microvesicles Messengers and mediators of tumor progression
Khalid Al-Nedawi et al.
CELL CYCLE (2009)
The tumor microenvironment and metastatic disease
Sarah Jane Lunt et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab
Angelica Calleri et al.
CLINICAL CANCER RESEARCH (2009)
Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
Heidi Schwarzenbach et al.
CLINICAL CANCER RESEARCH (2009)
The clonal evolution of metastases from primary serous epithelial ovarian cancers
Lalarukh Khalique et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A simple biological imaging system for detecting viable human circulating tumor cells
Toru Kojima et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection
John Yee et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients
Z. Cao et al.
NEOPLASMA (2009)
Parallel progression of primary tumours and metastases
Christoph A. Klein
NATURE REVIEWS CANCER (2009)
The staging of cancer: A retrospective and prospective appraisal
Frederick L. Greene et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
PRL PTPs: mediators and markers of cancer progression
Darrell C. Bessette et al.
CANCER AND METASTASIS REVIEWS (2008)
Circulating tumor cells and bone marrow micrometastasis
Catherine Alix-Panabieres et al.
CLINICAL CANCER RESEARCH (2008)
Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
Jean-Yves Pierga et al.
CLINICAL CANCER RESEARCH (2008)
Intercellular transfer of the oncogenic receptor EGFrvIII by microvesicles derived from tumour cells
Khalid Al-Nedawi et al.
NATURE CELL BIOLOGY (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer
Michail Ignatiadis et al.
CLINICAL BREAST CANCER (2007)
Circulating tumor cells: detection, molecular profiling and future prospects
Korine Jacob et al.
EXPERT REVIEW OF PROTEOMICS (2007)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Different prognostic value of cytokeratin-19 mRNA-positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer
Michail Ignatiadis et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
Atherosclerosis and vascular aging as modifiers of tumor progression, angiogenesis, and responsiveness to therapy
Halka Klement et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Patrizia Paterlini-Brechot et al.
CANCER LETTERS (2007)
In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry
Wei He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Genes that distinguish physiological and pathological angiogenesis
Steven Seaman et al.
CANCER CELL (2007)
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer:: A validation study of the CellSearch system
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2007)
Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer
Heidi Schwarzenbach et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The clinical significance of disseminated tumor cells in breast cancer
Martin J. Slade et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Mechanisms of heparin induced anti-cancer activity in experimental cancer models
T. M. H. Niers et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
Preparing the Soil: The premetastatic niche
Rosandra N. Kaplan et al.
CANCER RESEARCH (2006)
Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene
Hartmut Schmidt et al.
CANCER RESEARCH (2006)
Mechanisms of Disease: oncogene addiction - a rationale for molecular targeting in cancer therapy
I. Bernard Weinstein et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Circulating tumor cells: the 'leukemic phase' of solid cancers
S Mocellin et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors
A Nanda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
Massimo Cristofanilli
SEMINARS IN ONCOLOGY (2006)
Metastasis predictive signature profiles pre-exist in normal tissues
HY Yang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1
YG Park et al.
NATURE GENETICS (2005)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer
TA Martin et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases
M Koch et al.
ANNALS OF SURGERY (2005)
Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas
W Biernat et al.
BRAIN PATHOLOGY (2004)
Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients
JY Pierga et al.
CLINICAL CANCER RESEARCH (2004)
A rare-cell detector for cancer
RT Krivacic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer:: A predictive molecular marker of metachronous liver and lung metastases
H Kato et al.
CLINICAL CANCER RESEARCH (2004)
Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method
B Naume et al.
CYTOTHERAPY (2004)
Classification of isolated tumor cells - Clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual
SE Singletary et al.
CANCER (2003)
A molecular signature of metastasis in primary solid tumors
S Ramaswamy et al.
NATURE GENETICS (2003)
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
CA Klein et al.
LANCET (2002)
Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors
O Solakoglu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The seed and soil hypothesis: vascularisation and brain metastases
IJ Fidler et al.
LANCET ONCOLOGY (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood
KJ Martin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Isolation by size of epithelial tumor cells - A new method for the immunomorphological and molecular characterization of circulating tumor cells
G Vona et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Molecular biology of breast cancer metastasis - Clinical implications of experimental studies on metastatic inefficiency
AF Chambers et al.
BREAST CANCER RESEARCH (2000)
分享论文
